Search Results 931-940 of 16858 for polycystic ovary syndrome
Researchers conduct clinical trials to test new drug therapies. Investigators are working to better understand the gene mutations involved in myelodysplastic ...
The Early-Onset Parkinson's Disease and Synucleinopathies Lab led by Rodolfo Savica, M.D., Ph.D., translates research into improved diagnosis, treatment and ...
SAN DIEGO — A drug therapy shows promise for treating an inherited form of kidney disease called autosomal dominant polycystic kidney disease (ADPKD), Mayo ...
Search for a disease or condition . Type 3 or more letters to display suggested search options. When results are available, use up and down arrow keys to ...
The purpose of this study is to determine the safety profile, maximum tolerated dose (MTD), dose-limiting toxicities (DLT), and recommended Phase 2 dose (RP2D) ...
For years, Canna's life revolved around waiting for a transplant. Due to her family medical history, and because polycystic kidney disease is hereditary, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study ...
About this study. The purpose of this study is to determine whether patients with autosomal dominant polycystic kidney disease (ADPKD) present with abnormal ...
About this study. The patient has failed all other available agents and has intractable epilepsy due to Dravet Syndrome. Stiripentol is highly efficacious ...
Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.